Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other: 2022

  • Kiniksa Pharmaceuticals International's Receivables - Other was N/A to $7.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $7.7 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Receivables - Other of $7.7 million as of Q4 2022.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Receivables - Other ranged from a high of $7.7 million in Q4 2022 and a low of $7.7 million during Q4 2022.
  • For the 1-year period, Kiniksa Pharmaceuticals International's Receivables - Other averaged around $7.7 million, with its median value being $7.7 million (2022).